Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

MM6: Racial Disparities and COVID-19–Associated Illness and Death

In this presentation, Dr. Adaora Adimora discusses the disproportionate number of COVID-19 cases and deaths among Black and Latinx populations and factors that influence these disparities.
Ada Adimora, MD, MPH
Released: June 25, 2020

Information on this Educational Activity

Faculty

Ada Adimora, MD, MPH

Sarah Graham Kenan Distinguished Professor of Medicine
Attending

Division of Infectious Diseases
Department of Medicine
The University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

Adaora A. Adimora, MD, MPH has disclosed that she has received funds for research support from Gilead Sciences and consulting fees from Gilead Sciences, Merck, and ViiV Healthcare.

Program Medium

This program has been made available online.

Related Content

Clinical Care Options’ (CCO) commentary from Dr. Vikramjit Mukherjee on the association between surges in COVID-19 caseload and mortality.

Vikramjit Mukherjee, MD Released: September 3, 2021

Downloadable slides from CCO on the rationale and evidence supporting timeliness in the administration of therapies that act directly against SARS-CoV-2

Arthur Kim, MD Lynora Saxinger, MD, FRCPC, CTropMed Released: August 25, 2021

Concise Clinical Care Options (CCO) presentation by Arthur Kim, MD, on emerging oral antiviral options for outpatient treatment of SARS-CoV-2 infection

Arthur Kim, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: August 25, 2021 Expired: August 24, 2022

From Dr. Josep M. Llibre and Clinical Care Options (CCO), expert commentary reviewing recent data about the potential therapeutic role of TDF in SARS-CoV-2 infection

Josep M. Llibre, MD, PhD Released: August 16, 2021
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Educational grant provided by
Gilead Sciences, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue